Hui Liu - Apr 4, 2022 Form 4 Insider Report for Rallybio Corp (RLYB)

Role
Director
Signature
By: /s/ Michael Greco, Attorney-in-Fact
Stock symbol
RLYB
Transactions as of
Apr 4, 2022
Transactions value $
$0
Form type
4
Date filed
4/6/2022, 07:59 PM
Previous filing
Feb 2, 2022
Next filing
May 26, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLYB Option (Right to Buy) Award $0 +26.9K $0.00 26.9K Apr 4, 2022 Common Stock 26.9K $8.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is granted under the Company's 2021 Equity Incentive Plan. The option vests in three equal annual installments beginning on April 4, 2023.